Calcipotriene CAS 112828-00-9
Longchang source page for Calcipotriene / Calcipotriol, source-record CAS 112828-00-9. Because public identifier records are not uniform, send the required name, CAS basis, stereochemistry, hydration state, identity method, target specification and quantity to request current identity confirmation, analytical methods, applicable lot COA, SDS status, sample availability, packaging, MOQ, current availability and confirmed lead time.
Identity fields to confirm
| Product names | Calcipotriene (USAN); Calcipotriol (INN) |
|---|---|
| Longchang source-record CAS | 112828-00-9; current controlled confirmation required |
| PubChem record | CID 5288783 |
| Anhydrous formula | C27H40O3 |
| Anhydrous molecular weight | 412.6 g/mol (reviewed DailyMed label: 412.62) |
| InChIKey | LWQQLNNNIPYSNX-UROSTWAQSA-N |
| Material-basis check | Anhydrous active moiety, monohydrate or another declared form |
PubChem currently lists 112965-21-6 under CAS, continues to associate 112828-00-9 through an ECHA contribution and labels 112828-00-9 as deprecated in a ChemIDplus contribution. NIH NCATS/GSRS aggregation also associates 112828-00-9 with the Calcipotriene active-moiety record. The current RFQ should resolve the identifier and material basis rather than relying on the URL alone.
Information to request for qualification
| Qualification item | What to define or request |
|---|---|
| Идентичность | Controlled names, CAS basis, stereochemistry, hydration/solvate state, formula, molecular weight, identity method, reference standard and acceptance criteria |
| Анализ | Required limit, analytical method, units, anhydrous/hydrate reporting basis and applicable lot result |
| Внешний вид | Required controlled description, method, test conditions and acceptance criteria |
| Water / hydration | Named method, units, limit and relationship to the declared material and assay basis |
| Impurity profile | Required related substances, residual solvents, elemental impurities or buyer-specific fields with methods and limits |
| Technical context | Intended function, process/formulation context, quality standard, product category and destination market |
| Documents | Current supplier specification, applicable lot COA, current SDS and requested declarations or questionnaires |
| Commercial details | Sample quantity, full quantity, MOQ, current availability, quotation validity, packaging, destination and lead time |
Historical source-record fields
The previous page displayed the fields below without a visible current controlled specification number, hydration basis, complete method set, lot identity, effective date or approval status. They are historical sourcing context only. They are not a current Longchang specification, lot result, grade statement, compendial claim or regulatory declaration.
| Historical field | Old page value | Current evidence required |
|---|---|---|
| Name / CAS | Calcipotriene, CAS 112828-00-9 | Current controlled names, identifier basis, stereochemistry and identity method |
| Formula / molecular weight | C27H40O3 / 412.6 | Declared material basis and consistency with the current specification and assay calculation |
| Внешний вид | “WHITE powder” | Controlled wording, method, conditions, limit and applicable lot result |
| Категория | API database category | Buyer quality standard, intended context, regulatory pathway and supporting documents |
| Использование | Finished-drug treatment claim | Removed from this raw-material sourcing page; finished-product decisions require the applicable label and competent review |
Anhydrous, hydrate and finished-product boundary
Сайт reviewed current DailyMed ointment label states the anhydrous formula C27H40O3 and molecular weight 412.62. Other DailyMed cream and solution labels describe Calcipotriene monohydrate, C27H40O3·H2O, with molecular weight 430.6. A quotation must identify which material basis is offered and how assay is reported.
A DailyMed label belongs to the named finished prescription product. It does not establish that a current Longchang lot is an approved drug, approved dosage form, pharmacopeial grade, equivalent formulation or suitable for a buyer’s market. Patient directions, treatment duration, adverse-event advice and clinical results from a finished label are not raw-material usage instructions.
Application and regulatory boundary
The database category `Api`, an ingredient name, a CAS association or a finished-product label does not by itself establish manufacturing authorization, GMP status, compendial compliance, regulatory filing support or suitability for a buyer’s finished product. Qualification must cover identity and material basis, assay and impurities, process/formulation, safety controls, quality agreements, current destination-market rules and the buyer’s approval requirements.
Safety and handling boundary
This page is not a substitute for an SDS or a site-specific risk assessment. Request the current supplier SDS and use it with local rules and the buyer’s procedures to define classification, receipt, storage, transfer, processing, transport and disposal controls for the material supplied. Finished-product safety and patient information require a separate competent review of the actual formulation and applicable labeling.
Read the identity and label-context guide
Review the Calcipotriene and Calcipotriol identity guide for name equivalence, CAS-source differences, anhydrous versus monohydrate interpretation, the steroid-classification question and the boundary between chemical records and finished-drug labels.
Request a specification, COA, SDS or sample
Электронная почта info@longchangchemical.com and include:
- Calcipotriene / Calcipotriol and the required name, CAS and material basis;
- required stereochemistry, hydration state, identity method and reference standard;
- intended technical context, buyer quality standard and destination market;
- required tests, methods, units, limits and any buyer specification;
- sample quantity, full quantity, packaging constraints and destination;
- required documents and requested delivery window.